Compile Data Set for Download or QSAR
Report error Found 556 Enz. Inhib. hit(s) with all data for entry = 13292
TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM774500(US20250304537, Compound 362)
Affinity DataIC50: 2nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM774596(US20250304537, Compound 458)
Affinity DataIC50: 2nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM774233(US20250304537, Compound 94)
Affinity DataIC50: 2nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM774538(US20250304537, Compound 400)
Affinity DataIC50: 2nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM774200(US20250304537, Compound 61)
Affinity DataIC50: 2nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM774696(US20250304537, Compound 937)
Affinity DataIC50: 2nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM774695(US20250304537, Compound 936)
Affinity DataIC50: 2nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM774205(US20250304537, Compound 66)
Affinity DataIC50: 2nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM774185(US20250304537, Compound 45)
Affinity DataIC50: 2nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM774541(US20250304537, Compound 403)
Affinity DataIC50: 2nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM774635(US20250304537, Compound 606)
Affinity DataIC50: 2nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM774206(US20250304537, Compound 67)
Affinity DataIC50: 2nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM774366(US20250304537, Compound 227)
Affinity DataIC50: 2nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM774521(US20250304537, Compound 383)
Affinity DataIC50: 2nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM774415(US20250304537, Compound 276)
Affinity DataIC50: 2nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM774621(US20250304537, Compound 483)
Affinity DataIC50: 2nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM774619(US20250304537, Compound 481)
Affinity DataIC50: 2nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM774689(US20250304537, Compound 901)
Affinity DataIC50: 3nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM774229(US20250304537, Compound 90)
Affinity DataIC50: 3nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM774566(US20250304537, Compound 428)
Affinity DataIC50: 3nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM774630(US20250304537, Compound 601)
Affinity DataIC50: 3nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM774694(US20250304537, Compound 908)
Affinity DataIC50: 3nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM774228(US20250304537, Compound 89)
Affinity DataIC50: 3nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM774693(US20250304537, Compound 905)
Affinity DataIC50: 3nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM774230(US20250304537, Compound 91)
Affinity DataIC50: 3nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM774166(US20250304537, Compound 26)
Affinity DataIC50: 3nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM774405(US20250304537, Compound 266)
Affinity DataIC50: 3nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM774572(US20250304537, Compound 434)
Affinity DataIC50: 3nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM774673(US20250304537, Compound 831)
Affinity DataIC50: 3nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM774480(US20250304537, Compound 342)
Affinity DataIC50: 3nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM774671(US20250304537, Compound 829)
Affinity DataIC50: 3nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM774614(US20250304537, Compound 476)
Affinity DataIC50: 3nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM774677(US20250304537, Compound 843)
Affinity DataIC50: 3nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM774681(US20250304537, Compound 881)
Affinity DataIC50: 3nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM774615(US20250304537, Compound 477)
Affinity DataIC50: 3nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM774685(US20250304537, Compound 893)
Affinity DataIC50: 3nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM774390(US20250304537, Compound 251)
Affinity DataIC50: 3nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM774657(US20250304537, Compound 766)
Affinity DataIC50: 3nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM774178(US20250304537, Compound 38)
Affinity DataIC50: 3nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM774602(US20250304537, Compound 464)
Affinity DataIC50: 3nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM774471(US20250304537, Compound 333)
Affinity DataIC50: 3nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM774599(US20250304537, Compound 461)
Affinity DataIC50: 3nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM774667(US20250304537, Compound 805)
Affinity DataIC50: 3nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM774305(US20250304537, Compound 166)
Affinity DataIC50: 3nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM774413(US20250304537, Compound 274)
Affinity DataIC50: 3nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM774581(US20250304537, Compound 443)
Affinity DataIC50: 3nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM774515(US20250304537, Compound 377)
Affinity DataIC50: 3nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM774650(US20250304537, Compound 621)
Affinity DataIC50: 3nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM774585(US20250304537, Compound 447)
Affinity DataIC50: 3nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM774649(US20250304537, Compound 620)
Affinity DataIC50: 3nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/19/2026
Entry Details
US Patent

Displayed 1 to 50 (of 556 total ) | Next | Last >>
Jump to: